Lookout for these Two stocks: ENSCO plc (NYSE:ESV), ReShape Lifesciences Inc. (NASDAQ:RSLS)

0

ENSCO plc (NYSE:ESV)

ENSCO plc (NYSE:ESV) represented a move of -11.36 percent or $0.44 per share and closed its previous day trading session at $5.15. 26.43 Million Shares were traded in the last trading session with an Average Volume of 12.94 Million Shares. The stock currently has a Market Capitalization of 2.44 Billion.

Ensco International plc, formerly ENSCO International Incorporated, is a provider of offshore contract drilling services to the international oil and gas industry. The Company owns and operates drilling rigs including jackup, ultra-deepwater semisubmersible and barge rigs. Its drilling rigs are located throughout the world and concentrated in the major geographic regions of Asia Pacific (which includes Asia, the Middle East, Australia and New Zealand), Europe/Africa and North and South America. The Company provides drilling services on a day rate contract basis. Under day rate contracts, it provides the drilling rig and rig crews, and receives a fixed amount per day for drilling the well. Its customers bear substantially all of the ancillary costs of constructing the well and supporting drilling operations. The Company does not provide turnkey or other risk-based drilling services.

The stock traded between $4.10 and $9.51 over 1-Year time period showing its price to sales ratio of 1.39. ENSCO plc (NYSE:ESV) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $-30.54 and 200-Day Simple Moving Average of $-21.15. Its Price to Free Cash Flow is 0 and Price to Book of 0.27.

Analyst’s recommended the stock as 2.4 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, ENSCO plc (NYSE:ESV) reported its Actual EPS of $-0.33/share. The analysts offering Earnings Estimates for the company were believing that ENSCO plc could bring EPS of $-0.34/share. The difference between Actual EPS and Estimated EPS was 0.01 Percent. Thus showing an Earnings Surprise of 2.9 Percent.

ReShape Lifesciences Inc. (NASDAQ:RSLS)

In the last trading session, ReShape Lifesciences Inc. (NASDAQ:RSLS) added its value by 0.54% closing at the price of $0.76. The stock currently has market capitalization of 440000, with average volume of 1.08 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently ReShape Lifesciences Inc. (NASDAQ:RSLS) is showing beta of 2.13. This particular value of beta suggests that ReShape Lifesciences Inc. (NASDAQ:RSLS) has historically moved 213% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for ReShape Lifesciences Inc. (NASDAQ:RSLS) is at $-876.51.

The stock currently has RSI of 23.23. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

ReShape Lifesciences Inc. is a developer of invasive medical devices to treat obesity and metabolic diseases. The company’s portfolio includes vBloc System(R), ReShape(R) and Gastric Vest System (TM). ReShape Lifesciences Inc., formerly known as EnteroMedics Inc., is based in CA, United States.

ReShape Lifesciences Inc. (NASDAQ:RSLS) topped its 52-week high price of $3,759.000 on 01/25/18 and 52-Week Low Price of $0 / 0.700 on 12/06/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 10.64% and monthly volatility of 47.33% respectively.